| |
|
| |
| DETAILS |
|
How cutting-edge AI innovation & global partnerships are reshaping the next era of biopharma
This discussion will deliver decision-useful insights for founders, pharma executives, & investors navigating a potential seismic shift, where AI accelerates discovery timelines & reduces experimental failures.
What we'll explore
The prospect of China approving one of the first fully AI-designed drugs as early as next year - & what this means for U.S. biotech competition, partnerships, & IP strategy
Strategic lessons for pharma on collaborating with Chinese AI-biotech innovators while managing IP, regulatory, & compliance considerations
Where the biggest opportunities are emerging, from early discovery & generative design to clinical acceleration & global out-licensing
Insights from real deals & examples of how emerging players can position themselves for the next wave of growth
What AI-designed drugs really mean in practice - & how close the industry is to meaningful regulatory milestones
Moderated by: Gadareth Higgs
Gadareth Higgs, PhD, is a seasoned expert with over 15 years of postgraduate experience in bioinformatics, consulting, & healthcare. As a Due Diligence Analyst Partner at Advantary Capital Partners, he contributes to the firm's mission of combining deep operational expertise with strategic investment insight to help portfolio companies thrive. Through Higgs Insights, he has helped startups double investor interest, raise funding (up to $7.5M), prepare for pitches in only four days, & secure a $1M LP commitment. His previous experience includes leading precision oncology, biotechnology, & healthcare consulting initiatives at ConcertAI & McKinsey, where he guided large-scale transformations & due diligence for healthcare acquisitions exceeding $1B.
Who should attend
Founders in AI/biotech, R&D leaders, corporate strategy & business development executives, investors, & policy strategists seeking a practical, forward-looking view of China's role in AI-driven drug discovery.
|
|
|
|
|
|
|
|
